Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Weissinger

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Bone Marrow Transplantation|February 22, 2023
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyRaffaella Greco, Jorinde D Hoogenboom, Edouard F Bonneville, et al.
Leukemia|January 17, 2017
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCTM Neuenhahn, J Albrecht, M Odendahl, et al.
Proteomics. Clinical Applications|February 5, 2010
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsJoshua J Coon, Petra Zürbig, Mohammed Dakna, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Bone Marrow Transplantation|February 22, 2023
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyRaffaella Greco, Jorinde D Hoogenboom, Edouard F Bonneville, et al.
Leukemia|January 17, 2017
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCTM Neuenhahn, J Albrecht, M Odendahl, et al.
Proteomics. Clinical Applications|February 5, 2010
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsJoshua J Coon, Petra Zürbig, Mohammed Dakna, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Pageof 12